D. Altomare

Molecular Biology · 2005

A researcher in the Science corpus: 1 paper; trusts 5 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom D. Altomare trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. K. Inoki
  2. David Carling
  3. Julian Downward
  4. A. Bellacosa
  5. J. Testa
  6. P. Pandolfi
  7. D. Hanahan
  8. Jiyong Liang
  9. William Y. Kim
  10. I. Shiojima

Who trusts D. Altomare overall

  1. Ping Wee
  2. N. Turner
  3. P. Paoli

Papers from D. Altomare's perspective

Ordered by how strongly the researchers D. Altomare trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR (Proceedings of the National Academy of Sciences of the United States of America)
  2. TSC2 mediates cellular energy response to control cell growth and survival. (Cell)
  3. mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways (Nature Medicine)
  4. High Frequency of Mutations of the PIK3CA Gene in Human Cancers (Science)
  5. An inhibitor of mTOR reduces neoplasia and normalizes p70/S6 kinase activity in Pten+/− mice (Proceedings of the National Academy of Sciences of the United States of America)
  6. PTEN: One Gene, Many Syndromes (Human Mutation)
  7. Dysregulation of the TSC-mTOR pathway in human disease (Nature Genetics)
  8. Activation of AKT kinases in cancer: implications for therapeutic targeting. (Advances in Cancer Research)
  9. The biology and clinical relevance of the PTEN tumor suppressor pathway. (Journal of Clinical Oncology)
  10. PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma. (Cancer Research)

Their papers